These data let us examine the fibrinogen elimination by B220+CD11c+NK1.1+HepELs in the tumour‐bearing wild‐type mouse background, since fibrinogen deposition in tumour‐bearing FX−/− mice was more prominent than that in tumour‐bearing wild‐type mice. This evidence concerns the gene PTPRC and neoplasm.